The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 7,801–7,900 of 31,469
Ko, G. T. C., Chan, J. C. N., Tsang, L. W. W., Li, C.-Y., & Cockram, C. S. (1999) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1999.tb03138.x · Cited by 48
Choi, S.-Y., Kim, D., Kang, J. H., Park, M. J., Kim, Y. S., Lim, S. H., Kim, C. H., & Lee, H.-S. (2008) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2008.14.1.77 · Cited by 46
Kim, N. H., & Park, H. S. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.10.012 · Cited by 48
Antibodies to Endothelial Cells in Borderline Hypertension
Frostegård, J., Wu, R., Gillis‐Haegerstrand, C., Lemne, C. E., & Fairé, U. D. (1998) · Circulation · doi:10.1161/01.cir.98.11.1092 · Cited by 47
Ruige, J. B., Ballaux, D., Funahashi, T., Mertens, I. L., Matsuzawa, Y., & Gaal, L. F. V. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.82.1.21 · Cited by 46
Tham, E., Liu, J., Innis, S. M., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90866.2008 · Cited by 47
Zadelaar, A. S. M., Boesten, L. S. M., Jukema, J. W., van Vlijmen, B. J. M., Kooistra, T., EMEIS, J. J., Lundholm, E., Camejo, G., & Havekes, L. M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000242904.34700.66 · Cited by 47
Magkos, F., Patterson, B. W., Mohammed, B. S., & Mittendorfer, B. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00636.2006 · Cited by 46
Amin, M. M., & Arbid, M. S. (2016) · Applied Physiology Nutrition and Metabolism · doi:10.1139/apnm-2016-0429 · Cited by 47
de Rooij, S. R., Painter, R. C., Phillips, D. I. W., Osmond, C., Tanck, M. W. T., Defesche, J. C., Bossuyt, P. M., Michels, R. P. J., Bleker, O. P., & Roseboom, T. J. (2006) · Diabetes Care · doi:10.2337/dc05-1993 · Cited by 47
Giavoli, C., Cappiello, V., Corbetta, S., et al. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02067.x · Cited by 47
Evaluation of a standardized hyperglucidic breakfast test in postprandial reactive hypoglycaemia
Brun, J. ‐., F�dou, C., Bouix, O., de Mauverger, É. R., & Orsetti, A. (1995) · Diabetologia · doi:10.1007/bf00410289 · Cited by 45
Thomas, G. N., Critchley, J., Tomlinson, B., Anderson, P. J., Lee, Z. S. K., & Chan, J. C. N. (2000) · Metabolism · doi:10.1053/meta.2000.18512 · Cited by 49
Bunt, J. C., Salbe, A. D., Harper, I., Hanson, R. L., & Tataranni, P. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2524 · Cited by 46
Adamo, K. B., Sigal, R. J., Williams, K., Kenny, G. P., Prud’homme, D., & Tesson, F. (2005) · Diabetologia · doi:10.1007/s00125-005-1827-y · Cited by 46
Estrada, V., de Villar, N. G. P., Larrad, M. T. M., López, A. G., Fernández, C., & Serrano‐Ríos, M. (2002) · Clinical Infectious Diseases · doi:10.1086/340863 · Cited by 47
Chiu, K. C., & McCarthy, J. E. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90054-8 · Cited by 47
Ushula, T. W., Mamun, A., Darssan, D., Wang, W. Y. S., Williams, G. M., Whiting, S. J., & Najman, J. M. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.05.006 · Cited by 45
Hurd, W. W., Abdel-Rahman, M. Y., Ismail, S. A., Abdellah, M. A., Schmotzer, C. L., & Sood, A. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.07.002 · Cited by 46
Bhattacharya, K., Sengupta, P., Dutta, S., Chaudhuri, P., Das Mukhopadhyay, L., & Syamal, A. K. (2021) · Endocrine · doi:10.1007/s12020-020-02555-3 · Cited by 45
Park, J. H., Kim, J. Y., Choi, J. H., Park, H. S., Shin, H.-Y., Lee, J. M., Kim, J.-W., Ko, H.-J., Chon, S., Kim, B. K., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00739-z · Cited by 48
Chung, J. O., Koutsari, C., Blachnio-Zabielska, A. U., Hames, K. C., & Jensen, M. D. (2017) · Diabetes · doi:10.2337/db17-0082 · Cited by 45
Extreme hypertriglyceridemia: genetic diversity, pancreatitis, pregnancy, and prevalence
Chyzhyk, V., Kozmic, S., Brown, A. S., Hudgins, L. C., Starc, T. J., Davila, A. D., Blevins, T. C., Diffenderfer, M. R., He, L., Geller, A. S., et al. (2019) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2018.09.007 · Cited by 44
“Values for the homeostasis model assessment of insulin resistance (HOMA-IR) were calculated based on levels of fasting glucose and fasting insulin as previously described.(17)”
MethodThe role of insulin sensitivity and intranasally applied insulin on olfactory perception
Edwin Thanarajah, S., Hoffstall, V., Rigoux, L., Hanssen, R., Brüning, J. C., & Tittgemeyer, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-43693-7 · Cited by 46
Serum adropin level in patients with stable coronary artery disease
Zhao, L.-P., Xu, W.-T., Wang, L., You, T., Chan, S.-P., Zhao, X., & Yang, X.-J. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.03.008 · Cited by 46
Cazzo, E., JÚNIOR, F. G., Pareja, J. C., & Chaim, É. A. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1183-4 · Cited by 46
Zhang, W., Li, C., Liu, B., Wu, R., Zou, N., Xu, Y.-Z., Yang, Y., Zhang, F., Zhou, H.-M., Wan, K., et al. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31294-3 · Cited by 45
Obesity-Induced Insulin Resistance Is Mediated by High Uric Acid in Obese Children and Adolescents
Niu, Y., Tang, Q., Zhao, X., Zhao, X., Mao, X., Sheng, J., Cai, W., & Feng, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.773820 · Cited by 48
Garzia, E., Galiano, V., Marfia, G., Navone, S. E., Grossi, E., & Marconi, A. M. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00876-0 · Cited by 50
Multi-omics gut microbiome signatures in obese women: role of diet and uncontrolled eating behavior
Barone, M., Garelli, S., Rampelli, S., Agostini, A., Matysik, S., D’Amico, F., Krautbauer, S., Mazza, R., Salituro, N., Fanelli, F., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02689-3 · Cited by 56
Pencina, K. M., Valderrábano, R. J., Wipper, B., Orkaby, A. R., Reid, K. F., Storer, T. W., Lin, A. P., Merugumala, S. K., Wilson, L. A., Latham, N. K., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad027 · Cited by 48
Lee, W., Peng, L., Lin, M., Loh, C., Hsiao, F., & Chen, L. (2023) · Aging · doi:10.18632/aging.204508 · Cited by 49
Zeng, H., Liu, C., Wan, L., Peng, L., Wen, S., Fang, W., Chen, H., Wang, K., Yang, X., Huang, J., et al. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.138916 · Cited by 48
Zhu, Y., Wang, D., Zhou, S., & Zhou, T. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c00626 · Cited by 46
Gene expression of paired abdominal adipose AQP7 and liver AQP9 in patients with morbid obesity
Miranda, M., Ceperuelo‐Mallafré, V., Lecube, A., Hernández, C., Chacón, M. R., Fort, J. M., Gallart, L., Baena‐Fustegueras, J. A., Simó, R., & Vendrell, J. J. (2009) · Metabolism · doi:10.1016/j.metabol.2009.06.004 · Cited by 46
Mukai, N., Ninomiya, T., Hata, J., Hirakawa, Y., Ikeda, F., Fukuhara, M., Hotta, T., Koga, M., Nakamura, U., Kang, D., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0247-7 · Cited by 46
Alves, R. D. M., Moreira, A. P. B., Macedo, V. S., Bressan, J., Alfenas, R. D. C. G., Mattes, R. D., & Costa, N. M. B. (2014) · Obesity · doi:10.1002/oby.20825 · Cited by 46
Geidenstam, N., Spégel, P., Mulder, H., Filipsson, K., Ridderstråle, M., & Danielsson, A. P. H. (2014) · Obesity · doi:10.1002/oby.20868 · Cited by 47
Cruz, M. A. F., Cruz, J. F., Macena, L. B., de Santana, D. S., Oliveira, C. C. D. C., Lima, S. O., & França, A. V. C. (2015) · Gastroenterology Research · doi:10.14740/gr685w · Cited by 47
Owecki, M., Nikisch, E., & Sowiński, J. (2006) · Acta Clinica Belgica · doi:10.1179/acb.2006.013 · Cited by 46
Elevated levels of C-reactive protein as a risk factor for Metabolic Syndrome in Indians
Mahajan, A., Jaiswal, A., Tabassum, R., Podder, A., Ghosh, S., Madhu, S. V., Mathur, S. K., Tandon, N., & Bharadwaj, D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.10.031 · Cited by 46
Masquio, D. C. L., de Piano, A., Campos, R. M. D. S., Sanches, P. D. L., Carnier, J., Corgosinho, F. C., Netto, B. D. M., de Carvalho‐Ferreira, J. P., Oyama, L. M., do Nascimento, C. M. O., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515001129 · Cited by 46
Xin, Y., Song, Z., Zhao, C., et al. (2010) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1000105 · Cited by 46
Insulin Breast Cancer Connection: Confirmatory Data Set the Stage for Better Care
DeCensi, A., & Gennari, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.3022 · Cited by 45
Bennetzen, M., Wellner, N., Ahmed, S., Ahmed, S. M., Diep, T. A., Hansen, H. S., Richelsen, B., & Pedersen, S. B. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.8 · Cited by 47
Treatment with silybin‐vitamin E‐phospholipid complex in patients with hepatitis C infection
Falasca, K., Ucciferri, C., Mancino, P., Vitacolonna, E., Tullio, D. D., Pizzigallo, E., Conti, P., & Vecchiet, J. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21292 · Cited by 45
Agrawal, S., Duseja, A. K., Aggarwal, A. N., Das, A., Mehta, M., Dhiman, R. K., & Chawla, Y. K. (2015) · Hepatology International · doi:10.1007/s12072-015-9615-3 · Cited by 46
Insulin Resistance in Type 2 Diabetes Mellitus May Be Related to Bone Mineral Density
Arikan, S., Tuzcu, A., Bahçeci, M., et al. (2012) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2011.11.005 · Cited by 46
Aypak, C., Türedi, Ö., & Yüce, A. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2177-2 · Cited by 47
Marullo, L., Moustafa, J. S. E.-S., & Prokopenko, I. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0551-8 · Cited by 48
Islam, A., Civitarese, A. E., Hesslink, R. L., & Gallaher, D. D. (2011) · Obesity · doi:10.1038/oby.2011.341 · Cited by 47
Heise, T., Morrow, L., Hompesch, M., Häring, H., Kapitza, C., Abt, M., Ramsauer, M., Magnone, M. C., & Fuerst‐Recktenwald, S. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12317 · Cited by 46
Lindmark, S., Burén, J., & Eriksson, J. W. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02593.x · Cited by 45
Shaker, O. G., El‐Shehaby, A., Zakaria, A., Mostafa, N., Talaat, S., Katsiki, N., & Mikhailidis, D. P. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.08.1148 · Cited by 46
Acute Thyroid Hormone Withdrawal in Athyreotic Patients Results in a State of Insulin Resistance
Brenta, G., Celi, F. S., Pisarev, M. A., Schnitman, M., Sinay, I. R., & Arias, P. (2009) · Thyroid · doi:10.1089/thy.2009.0108 · Cited by 46
Boyraz, M., Çekmez, F., Karaoğlu, A., et al. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.13 · Cited by 46
Masulli, M., Riccardi, G., Galasso, R., et al. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.06.005 · Cited by 46
Increased Plasma Retinol Binding Protein 4 Levels in Patients with Inflammatory Cardiomyopathy
Bobbert, P., Weithäuser, A., Andres, J., Bobbert, T., Kühl, U., Schultheiß, H., Rauch, U., & Skurk, C. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp153 · Cited by 46
Mikus, C. R., Fairfax, S. T., Libla, J. L., Boyle, L. J., Vianna, L. C., Oberlin, D. J., Uptergrove, G. M., Deo, S. H., Kim, A., Kanaley, J. A., et al. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00489.2011 · Cited by 48
Insulin sensitivity in Chinese ovo-lactovegetarians compared with omnivores
Kuo, C.-S., Lai, N.-S., Lt, H., & Lin, C.-L. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601783 · Cited by 47
Determining the Waist Circumference in African Americans Which Best Predicts Insulin Resistance
Sumner, A. E., Sen, S., Ricks, M., Frempong, B. A., Sebring, N. G., & Kushner, H. (2008) · Obesity · doi:10.1038/oby.2008.11 · Cited by 46
Araneta, M. R. G., & Barrett-Connor, E. L. (2007) · Obesity · doi:10.1038/oby.2007.291 · Cited by 46
Dairy Consumption and Insulin Resistance: The Role of Body Fat, Physical Activity, and Energy Intake
Tucker, L. A., Erickson, A. R., LeCheminant, J. D., & Bailey, B. W. (2015) · Journal of Diabetes Research · doi:10.1155/2015/206959 · Cited by 47
Effect of Dexamethasone on Oral Glucose Tolerance in Healthy Adults
Abdelmannan, D. K., Tahboub, R., GENUTH, S. M., & Ismail‐Beigi, F. (2010) · Endocrine Practice · doi:10.4158/ep09373.or · Cited by 48
Relationship Between Adiponectin and Ambulatory Blood Pressure in Obese Adolescents
Shatat, I. F., Freeman, K. D., Vuguin, P. M., DiMartino-Nardi, J., & Flynn, J. T. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819ea776 · Cited by 46
Miele, L., Forgione, A., Torre, G. L., Vero, V., Cefalo, C., Racco, S., Vellone, V. G., Vecchio, F. M., Gasbarrini, A., Rapaccini, G. L., et al. (2009) · Translational research · doi:10.1016/j.trsl.2009.06.007 · Cited by 46
Pal, S., Blais, J. M., Robidoux, M. A., Haman, F., Krümmel, E. M., Seabert, T., & Imbeault, P. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.01.006 · Cited by 46
Hamed, E. A., Zakary, M. M., Ahmed, N. S., & Gamal, R. M. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.08.023 · Cited by 45
Insulin-sensitive obese children display a favorable metabolic profile
Vuković, R., Mitrović, K., Milenković, T., Todorovic, S., Soldatović, I., Grujičić, S. Š., & Zdravković, D. (2012) · European Journal of Pediatrics · doi:10.1007/s00431-012-1867-5 · Cited by 46
Huang, X., Sjögren, P., Ärnlöv, J., Cederholm, T., Lind, L., Stenvinkel, P., Lindholm, B., Risérus, U., & Carrero, J. J. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12130 · Cited by 47
Fukuda, H., Imamura, M., Tanaka, Y., Iwata, M., Hirose, H., Kaku, K., Maegawa, H., Watada, H., Tobe, K., Kashiwagi, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046263 · Cited by 45
Koren, D., Chirinos, J. A., Katz, L. E. L., Mohler, E. R., Gallagher, P. R., Mitchell, G. F., & Marcus, C. L. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.67 · Cited by 48
Sprung, V. S., Cuthbertson, D. J., Pugh, C. J. A., Aziz, N., Kemp, G. J., Daousi, C., GREEN, D. J., Cable, N. T., & Jones, H. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31829ba9a1 · Cited by 46
Gracey, M. S., Bridge, E., Martin, D. D., Jones, T. W., Spargo, R. M., Shephard, M. D. S., & Davis, E. A. (2006) · PubMed · Cited by 46
Karatzi, K., Moschonis, G., Barouti, A. A., Lionis, C. D., Chrousos, G. P., & Μanios, Y. (2014) · Public Health Nutrition · doi:10.1017/s1368980013003327 · Cited by 49
Lasram, M. M., Bouzid, K., Douib, I. B., Annabi, A. B., Elj, N. E., Fazâa, S. E., Abdelmoula, J., & Gharbi, N. (2014) · Drug and Chemical Toxicology · doi:10.3109/01480545.2014.933348 · Cited by 46
Sprung, V. S., Cuthbertson, D. J., Pugh, C. J. A., Daousi, C., Atkinson, G., Aziz, N., Kemp, G. J., GREEN, D. J., Cable, N. T., & Jones, H. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.246918 · Cited by 47
Holligan, S. D., West, S. G., Gebauer, S. K., Kay, C. D., & Kris‐Etherton, P. M. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001561 · Cited by 46
Insulin Resistance and Environmental Pollutants: Experimental Evidence and Future Perspectives
Hectors, T. L. M., Vanparys, C., Gaal, L. F. V., Jorens, P. G., Covaci, A., & Blust, R. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1307082 · Cited by 48
Yarasheski, K. E., Cade, W. T., Overton, E. T., Mondy, K. E., Hubert, S., Laciny, E., Bopp, C., Lassa‐Claxton, S., & Reeds, D. N. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00468.2010 · Cited by 51
Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus
Al‐Harithy, R. N., & AlGhamdi, S. A. (2005) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2005.283 · Cited by 46
Zhao, J., Zhao, Y., Wang, H., Gu, X., Ji, J., & Gao, C. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-49 · Cited by 46
Fritsch, P. O., Kleber, M., Rosenkranz, A., Fritsch, M., Muntean, W. E., Mangge, H., & Reinehr, T. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.06.028 · Cited by 46
Mrizak, I., Arfa, A., Fekih, M., Debbabi, H., Bouslema, A., Boumaiza, I., Zaouali, M., Khan, N. A., & Tabka, Z. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-93 · Cited by 44
Relationship between oxidative stress, ferritin and insulin resistance in sickle cell disease.
Al‐Sultan, A. I., Seif, M. A., Amin, T. T., Mr, A. N., & AlSuliman, A. M. (2010) · PubMed · Cited by 48
Lana, A., Rodríguez‐Artalejo, F., & López‐García, E. (2014) · Journal of Nutrition · doi:10.3945/jn.114.195230 · Cited by 52
Gen, R., Akbay, E., Muşlu, N., Sezer, K., & Çayan, F. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802585613 · Cited by 46
Insulin Resistance as a Predictor of Cardiovascular Disease in Patients on peritoneal dialysis
Li, Y., Zhang, L., Gu, Y., Hao, C., & Zhu, T. (2013) · Peritoneal Dialysis International · doi:10.3747/pdi.2012.00037 · Cited by 46
Song, F., Li, X., Zhang, M., Yao, P., Yang, N., Sun, X., Hu, F. B., & Liu, L. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp196 · Cited by 46
Study of Omentin1 and Other Adipokines and Hormones in PCOS Patients.
Mahde, A., Shaker, M., & AL-Mashhadani, Z. I. (2009) · Europe PMC (PubMed Central) · doi:10.5001/omj.2009.25 · Cited by 46
McGee, K. C., Harte, A. L., da Silva, N. F., Al‐Daghri, N. M., Creely, S. J., Kusminski, C. M., Tripathi, G., Levick, P. L., Khanolkar, M., Evans, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020287 · Cited by 46
Sato, K., Iemitsu, M., Aizawa, K., Mesaki, N., & Fujita, S. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00564.2010 · Cited by 46
Ormseth, M. J., Oeser, A. M., Cunningham, A., Bian, A., Shintani, A., Solus, J. F., Tanner, S. B., & Stein, C. M. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4290 · Cited by 47
Association of Lactate With Blood Pressure Before and After Rapid Weight Loss
Crawford, S., Ambrose, M. S., Hoogeveen, R. C., Brancati, F. L., Ballantyne, C. M., & Young, J. H. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.282 · Cited by 46
Olatunji, L. A., & Soladoye, A. O. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.09.004 · Cited by 46
Is Socioeconomic Position Related to the Prevalence of Metabolic Syndrome?
Ramsay, S. E., Whincup, P. H., Morris, R. W., LENNON, L. T., & Wannamethee, S. G. (2008) · Diabetes Care · doi:10.2337/dc08-1158 · Cited by 46
Manco, M., Morandi, A., Marigliano, M., Rigotti, F., Manfredi, R. M., & Maffeis, C. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.11.023 · Cited by 46
Svensson, H., Wetterling, L., Bosaeus, M., Odén, B., Odén, A., Jennische, E., Edén, S., Holmäng, A. B., & Lönn, M. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.232 · Cited by 46
Major changes in the sphingophospholipidome of HDL in non-diabetic patients with metabolic syndrome
Denimal, D., Nguyen, A., de Barros, J.-P. P., Bouillet, B., Petit, J., Vergès, B. L., & Duvillard, L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.12.042 · Cited by 46
Koren, D., Gozal, D., Bhattacharjee, R., Philby, M. F., & Gozal, D. (2015) · CHEST Journal · doi:10.1378/chest.15-1543 · Cited by 47
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
